creatine has been researched along with Osteoporosis in 19 studies
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcopenia is associated with other age-related conditions such as osteoporosis, frailty and cachexia." | 6.82 | Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia. ( Candow, DG; Chilibeck, PD; Fairman, CM; Forbes, SC; Gualano, B; Roschel, H, 2022) |
| "Hyperhomocysteinemia may contribute to the development of osteoporosis." | 3.73 | Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. ( de Groot, LC; Dhonukshe-Rutten, RA; Lips, P; Pluijm, SM; Smit, JH; van Staveren, WA, 2005) |
| "Two hundred postmenopausal women with osteopenia were randomly allocated to receive either creatine monohydrate (3 g/d) or placebo for 2 years." | 2.94 | Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial. ( Alvarenga, JC; Benatti, FB; Gonçalves, N; Gualano, B; Pinto, AJ; Rodrigues Pereira, RM; Rodrigues, SF; Sales, LP; Sampaio-Barros, MM, 2020) |
| "Sarcopenia is associated with other age-related conditions such as osteoporosis, frailty and cachexia." | 2.82 | Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia. ( Candow, DG; Chilibeck, PD; Fairman, CM; Forbes, SC; Gualano, B; Roschel, H, 2022) |
| "Osteoporosis in beta-thalassemia major has emerged as a topic of interest since optimized transfusion regimens have increased life expectancy and quality in these patients." | 2.71 | Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis. ( Fiore, CE; Pennisi, P; Pizzarelli, G; Riccobene, S; Spina, M, 2003) |
| " It is likely that a higher dosage would be more effective, but would cause the potential endometrial effects." | 2.65 | Bone loss during oestriol therapy in postmenopausal women. ( Clark, AC; Garwood, J; Hart, DM; Kraszewski, A; Lindsay, R; Maclean, A, 1979) |
| "Furthermore, congestive heart failure is associated with impaired creatinine clearance and increased urea and urate, and osteoporosis and hip fractures are characterized by low albumin and cholesterol." | 1.32 | Association of biochemical values with morbidity in the elderly: a population-based Swedish study of persons aged 82 or more years. ( Berg, S; Evrin, PE; Johansson, B; McClearn, G; Nilsson, SE; Takkinen, S; Tryding, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (36.84) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Candow, DG | 3 |
| Chilibeck, PD | 2 |
| Forbes, SC | 3 |
| Fairman, CM | 1 |
| Gualano, B | 3 |
| Roschel, H | 2 |
| Kirk, B | 1 |
| Duque, G | 1 |
| Sales, LP | 1 |
| Pinto, AJ | 1 |
| Rodrigues, SF | 1 |
| Alvarenga, JC | 1 |
| Gonçalves, N | 1 |
| Sampaio-Barros, MM | 1 |
| Benatti, FB | 1 |
| Rodrigues Pereira, RM | 1 |
| Murai, IH | 1 |
| Pabis, LV | 1 |
| Takayama, L | 1 |
| de Oliveira, RB | 1 |
| Dos Santos Pereira, RT | 1 |
| Dantas, WS | 1 |
| Pereira, RM | 1 |
| Jorgetti, V | 1 |
| Ballester, RY | 1 |
| de Souza, RA | 1 |
| Xavier, M | 1 |
| da Silva, FF | 1 |
| de Souza, MT | 1 |
| Tosato, MG | 1 |
| Martin, AA | 1 |
| Castilho, JC | 1 |
| Ribeiro, W | 1 |
| Silveira, L | 1 |
| CLARK, CG | 1 |
| HAHNEMANN, S | 1 |
| FRIIS, T | 1 |
| HIGGINS, BA | 1 |
| NASSIM, JR | 1 |
| COLLINS, J | 1 |
| HILB, A | 1 |
| Pennisi, P | 1 |
| Pizzarelli, G | 1 |
| Spina, M | 1 |
| Riccobene, S | 1 |
| Fiore, CE | 1 |
| Nilsson, SE | 1 |
| Takkinen, S | 1 |
| Tryding, N | 1 |
| Evrin, PE | 1 |
| Berg, S | 1 |
| McClearn, G | 1 |
| Johansson, B | 1 |
| Seminari, E | 1 |
| Castagna, A | 1 |
| Soldarini, A | 1 |
| Galli, L | 1 |
| Fusetti, G | 1 |
| Dorigatti, F | 1 |
| Hasson, H | 1 |
| Danise, A | 1 |
| Guffanti, M | 1 |
| Lazzarin, A | 1 |
| Rubinacci, A | 1 |
| Dhonukshe-Rutten, RA | 1 |
| Pluijm, SM | 1 |
| de Groot, LC | 1 |
| Lips, P | 1 |
| Smit, JH | 1 |
| van Staveren, WA | 1 |
| Sahota, O | 1 |
| Masud, T | 1 |
| San, P | 1 |
| Hosking, DJ | 1 |
| Chlebna-Sokół, D | 1 |
| Loba-Jakubowska, E | 1 |
| Sikora, A | 1 |
| Lindsay, R | 1 |
| Hart, DM | 1 |
| Maclean, A | 1 |
| Garwood, J | 1 |
| Clark, AC | 1 |
| Kraszewski, A | 1 |
| Hulley, SB | 1 |
| Vogel, JM | 1 |
| Donaldson, CL | 1 |
| Bayers, JH | 1 |
| Friedman, RJ | 1 |
| Rosen, SN | 1 |
| Purnell, DC | 1 |
| Jones, JD | 1 |
| Becker, KL | 1 |
| Lemon, HM | 1 |
| Dworak, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial: Effects of Creatine Supplementation on Bone Mass and Turnover and Muscle Function in Healthy Postmenopausal Women[NCT01472393] | 200 participants (Anticipated) | Interventional | 2011-11-30 | Recruiting | |||
| Effects of Creatine and Caffeine Co-Supplementation on Muscle Mass and Muscle Performance in Trained Young Adults[NCT04290819] | 36 participants (Anticipated) | Interventional | 2019-02-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for creatine and Osteoporosis
| Article | Year |
|---|---|
Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia.
Topics: Aged; Cachexia; Creatine; Dietary Supplements; Frailty; Humans; Muscle Strength; Osteoporosis; Sarco | 2022 |
Current Evidence and Possible Future Applications of Creatine Supplementation for Older Adults.
Topics: Aged; Aged, 80 and over; Aging; Bone Density; Creatine; Dietary Supplements; Exercise; Female; Human | 2021 |
Creatine supplementation and aging musculoskeletal health.
Topics: Aging; Creatine; Humans; Osteoporosis; Resistance Training; Sarcopenia | 2014 |
3 trials available for creatine and Osteoporosis
| Article | Year |
|---|---|
Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial.
Topics: Absorptiometry, Photon; Accidental Falls; Aged; Bone Density; Bone Diseases, Metabolic; Brazil; Crea | 2020 |
Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis.
Topics: Adult; Amino Acids; beta-Thalassemia; Bone and Bones; Calcium; Clodronic Acid; Creatine; Humans; Inj | 2003 |
Bone loss during oestriol therapy in postmenopausal women.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Calcium; Clinical Trials as Topic; Creatine; Double-Bli | 1979 |
13 other studies available for creatine and Osteoporosis
| Article | Year |
|---|---|
Exercise training, creatine supplementation, and bone health in ovariectomized rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Combined Modality Therapy; Creatine; Die | 2015 |
Influence of creatine supplementation on bone quality in the ovariectomized rat model: an FT-Raman spectroscopy study.
Topics: Animals; Bone and Bones; Bone Density; Creatine; Dietary Supplements; Female; Osteoporosis; Ovariect | 2012 |
MALABSORPTION FOLLOWING PARTIAL GASTRECTOMY.
Topics: Alkaline Phosphatase; Blood; Body Weight; Calcium Metabolism Disorders; Calcium, Dietary; Celiac Dis | 1963 |
[REABSORPTION OF PHOSPHORUS IN THE RENAL TUBULES IN NONPARATHYROGENOUS DISEASES].
Topics: Adenoma; Bone Neoplasms; Breast Neoplasms; Creatine; Creatinine; Denmark; Diagnosis, Differential; H | 1964 |
THE EFFECT OF BENDROFLUAZIDE ON URINE CALCIUM EXCRETION.
Topics: Arthritis; Arthritis, Rheumatoid; Bendroflumethiazide; Calcium; Calcium Metabolism Disorders; Calciu | 1964 |
Association of biochemical values with morbidity in the elderly: a population-based Swedish study of persons aged 82 or more years.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Chemical Analysis; Body Mass Index; Cholesterol; Creatine | 2003 |
Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
Topics: Adult; Age Factors; Alkaline Phosphatase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bi | 2005 |
Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people.
Topics: Aged; Aged, 80 and over; Body Weight; Bone and Bones; Cohort Studies; Creatine; Female; Fractures, B | 2005 |
Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis.
Topics: 25-Hydroxyvitamin D 2; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Density; Bon | 1999 |
Clinical evaluation of patients with idiopathic juvenile osteoporosis.
Topics: Absorptiometry, Photon; Acute Disease; Adolescent; Alkaline Phosphatase; Body Mass Index; Bone Densi | 2001 |
The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest.
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Body Weight; Bone and Bones; Bone Resorption; Cal | 1971 |
Response to parathyroid hormone infusion in primary hyperparathyroidism.
Topics: Absorption; Calcium; Creatine; Graves Disease; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Tu | 1968 |
Association of human serum parathormone-like activity with pre-albumin electrophoretic zones.
Topics: Animals; Biological Assay; Blood Protein Electrophoresis; Calcium; Cattle; Chemistry Techniques, Ana | 1965 |